Lombard Odier Asset Management (USA)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19,398
Closed -$1.22M – 159
2026
Q1
$1.22M Sell
19,398
-2,710
-12% -$217K 0.13% 98
2025
Q4
$2.11M Sell
22,108
-5,716
-21% -$560K 0.2% 74
2025
Q3
$2.72M Buy
+27,824
New +$2.88M 0.18% 89
2018
Q3
– Sell
-7,500
Closed -$245K – 237
2018
Q2
$245K Buy
+7,500
New +$226K 0.02% 249
2016
Q4
– Sell
-20,000
Closed -$476K – 176
2016
Q3
$476K Buy
+20,000
New +$477K 0.04% 224

Other funds holding BSX

Lombard Odier Asset Management (USA)'s BSX Position: Q2 2026 in Review

Lombard Odier Asset Management (USA) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 19,398 shares — an estimated $1.22M sold.

Lombard Odier Asset Management (USA) first reported a position in BSX in Q3 2016 and held it in 5 quarters. The position peaked at $2.72M in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lombard Odier Asset Management (USA) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 19,398 Boston Scientific shares in Q2 2026, an estimated $1.22M.
  • Lombard Odier Asset Management (USA) first reported a position in Boston Scientific in Q3 2016 and held it in 5 quarters.
  • Lombard Odier Asset Management (USA)'s Boston Scientific position peaked at $2.72M in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2026, filed 14 Aug 2026.